Literature DB >> 2329893

[The significance of the preoperative CEA value for the prognosis of rectal cancer].

B Mentges1, R Brückner, C Weiss.   

Abstract

254 patients were operated for rectal carcinoma in the period from 1980 to 1986. The number of curative procedures, recurrence rate and 5-year-survival rate were dependent on the preoperative CEA levels, which correlated with the tumour stage. Even within tumour stages with enough cases for statistical evaluation the CEA could be established as an independent prognostical variable. Within stage pT2N0M0 recurrence rate for patients with preoperative CEA level below 5 ng/ml was 29% compared to 64% in patients with higher serum levels. Median survival time for the two groups were 65 and 35 months, respectively. In stage of lymph node involvement median survival times of 46 and 25 months were observed for the groups with CEA levels above and below 5 ng/ml. The pattern of recurrence within the two stages seemed to be unaffected by the preoperative CEA level. Patients with preoperative elevated CEA represent a risk group with need of consistent postoperative follow-up and CEA controls.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2329893     DOI: 10.1007/bf00713395

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  19 in total

1.  Sites of recurrent tumour after 'curative' colorectal surgery: implications for adjuvant therapy.

Authors:  J M Gilbert; I Jeffrey; M Evans; A E Kark
Journal:  Br J Surg       Date:  1984-03       Impact factor: 6.939

2.  Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer.

Authors:  H J Wanebo; B Rao; C M Pinsky; R G Hoffman; M Stearns; M K Schwartz; H F Oettgen
Journal:  N Engl J Med       Date:  1978-08-31       Impact factor: 91.245

3.  Pre- and postoperative uses of CEA.

Authors:  J T Evans; A Mittelman; M Chu; E D Holyoke
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

4.  Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma.

Authors:  M A Herrera; T M Chu; E D Holyoke
Journal:  Ann Surg       Date:  1976-01       Impact factor: 12.969

5.  CEA as a monitor of gastrointestinal malignancy.

Authors:  E D Holyoke; T M Chu; G P Murphy
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

6.  The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.

Authors:  R Goslin; G Steele; J Macintyre; R Mayer; P Sugarbaker; K Cleghorn; R Wilson; N Zamcheck
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

7.  The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.

Authors:  C G Moertel; J R O'Fallon; V L Go; M J O'Connell; G S Thynne
Journal:  Cancer       Date:  1986-08-01       Impact factor: 6.860

8.  Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.

Authors:  O C Lunde; O Havig
Journal:  Acta Chir Scand       Date:  1982

9.  Predictive value of plasma CEA levels: preoperative prognosis and postoperative monitoring of patients with colorectal carcinoma.

Authors:  J J Szymendera; M P Nowacki; A W Szawłowski; J A Kamińska
Journal:  Dis Colon Rectum       Date:  1982 Jan-Feb       Impact factor: 4.585

10.  Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma.

Authors:  H J Staab; F A Anderer; T Brümmendorf; E Stumpf; R Fischer
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.